Ireland
--:--IST
Recruiting Observational

Characterization and Prediction of Early Onset Diabetic Peripheral Neuropathy

NCT05546138 · tracked via the Priya Life Science Denmark tracker
Phase
Observational
Started
2023-10-01
Last updated
2024-06-28

Condition(s) studied

Neuropathy, DiabeticSmall Nerve Fiber NeuropathyType 1 Diabetes

Investigational drug(s) / intervention(s)

Skin biopsies with quantification of intra-epidermal nerve fibre densityPerception Threshold TrackingThermal perception thresholdsCorneal confocal MicroscopyMRINerve conduction studiesComposite scores and questionnaires

Skin biopsies with quantification of intra-epidermal nerve fibre density: Skin biopsy

Perception Threshold Tracking: Transcutaneous stimulation of large and small nerve fibres using weak electrical currents

Thermal perception thresholds: Heat and cold perception thresholds

Corneal confocal Microscopy: Corneal nerve fibre density, corneal nerve fibre length, corneal nerve branch density

MRI: Functional and structural MRI pictures of peripheral nerves and CNS

Nerve conduction studies: Nerve conduction and amplitude of Sural nerve

Composite scores and questionnaires: Composite scores and questionnaires

Study summary

Predicting early onset neuropathy in people with type 1 diabetes

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Men and women aged 18-80 years * Diagnosed with diabetes (of any type) * No clinically established diabetic peripheral neuropathy at inclusion Exclusion Criteria: * Alcohol or drug abuse within the last year (prior to inclusion) * Chemotherapy (prior or within study period) or experimental medicine * Severe vitamin deficiencies * Inability to understand or comply with the examinations * Planned or likely discontinuation of care at Aalborg University Hospital * Known hematologic disorders resulting in a markedly reduced ability to stop small bleedings * Severe limb ischemia * Active diabetic foot ulcers * Previous amputations * Severe skin diseases or diseases known to cause neural damage * Pregnancy at inclusion

Primary outcome measure(s)

  • Prediction of early onset neuropathy — 1,3,5,7,9 years
    Retrospective evaluation of the predictive power for each of the diagnostic tests
  • Comparison of Perception Threshold Tracking (PTT) and skin biopsies — 1-2 years
    Sensitivity, specificity, PPV, NPV of PTT compared to skin biopsies
  • Progression and regression of neuropathy — 1-9 years
    Description of the natural history of the development of neuropathy

Trial sites (1)

FacilityCityRegionStatus
Aalborg University Hospital Aalborg Denmark Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05546138 on ClinicalTrials.gov ↗ ← All trials in Denmark